A first-in-human phase I clinical trial of CXR1002 in patients (pts) with advanced cancer.
暂无分享,去创建一个
D. Bissett | C. Wolf | A. Barnett | I. Macpherson | C. Elcombe | T. Evans | R. Petty | L. Samuel | A. Jeynes-Ellis | J. MacDonald | M. Smith | B. Tait | J. Birse-Archbold